GLP-1 vs Qsymia: Which Weight Loss Medication Is Right for You?

If you're researching weight loss medications, you've likely encountered both GLP-1 medications like semaglutide and tirzepatide, as well as Qsymia. Both are FDA-approved for weight management, but they work in fundamentally different ways. Understanding these differences is crucial to finding the right approach for your health goals.

Let's break down how these medications compare, what the science tells us, and what you should consider when talking with your doctor.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that mimic a hormone your body naturally produces called glucagon-like peptide-1. This hormone plays a key role in regulating blood sugar and appetite.

Medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) work by activating GLP-1 receptors throughout your body. This triggers several effects: you feel fuller sooner when eating, your stomach empties more slowly, and your brain receives stronger signals that you're satisfied.

Originally developed for type 2 diabetes, these medications have shown remarkable effectiveness for weight loss in people without diabetes as well. They're administered as a once-weekly injection.

What Is Qsymia?

Qsymia is a combination pill containing two medications: phentermine and topiramate extended-release. Unlike GLP-1s, it's taken daily by mouth.

Phentermine is a stimulant that suppresses appetite and has been used for weight loss since the 1950s. Topiramate is an anti-seizure medication that also reduces appetite and makes food taste less appealing. Together in Qsymia, they're designed to work synergistically at lower doses than when used individually.

Qsymia has been FDA-approved for weight management since 2012 and represents one of the earlier prescription options in the modern weight loss medication landscape.

How They Work: Different Mechanisms

GLP-1: Hormonal Regulation

GLP-1 medications work with your body's existing metabolic pathways. They don't stimulate your nervous system or suppress appetite through stimulation. Instead, they normalize hunger signals that may have become dysregulated.

Many people describe the effect as finally feeling normal around food—not obsessing about the next meal, feeling satisfied with smaller portions, and experiencing reduced food noise in their minds.

Qsymia: Appetite Suppression and Stimulation

Qsymia takes a more direct approach to appetite suppression. The phentermine component stimulates your central nervous system, which can increase energy and reduce hunger. The topiramate component affects neurotransmitters in ways that further decrease appetite.

This combination can be effective, but it comes with the effects you'd expect from a stimulant medication.

Effectiveness: What the Research Shows

Clinical trials show both medications can lead to meaningful weight loss, though results vary.

GLP-1 medications have demonstrated impressive results in recent large-scale studies. Semaglutide (at the Wegovy dose) led to an average weight loss of about 15% of body weight over 68 weeks. Tirzepatide showed even more promising results, with participants losing an average of 15-20% of body weight depending on the dose.

Qsymia trials showed participants losing an average of 10% of their body weight over one year on the highest dose. While this is clinically meaningful, it's generally somewhat less than what's seen with newer GLP-1 medications.

It's important to remember that averages don't tell individual stories. Some people respond better to one medication than another based on their unique physiology.

Side Effects to Consider

GLP-1 Side Effects

The most common side effects of GLP-1 medications are gastrointestinal: nausea, occasional vomiting, diarrhea, and constipation. These typically improve over time and can be managed by starting at a low dose and increasing gradually.

Most people find these side effects manageable and temporary. Serious side effects are rare but can include pancreatitis and gallbladder problems.

Qsymia Side Effects

Because Qsymia contains a stimulant, side effects can include increased heart rate, tingling in hands and feet, dizziness, altered taste (especially with carbonated beverages), insomnia, dry mouth, and constipation.

Some people also experience anxiety or mood changes. Qsymia can increase heart rate and isn't recommended for people with certain cardiovascular conditions. It also carries a risk of birth defects and cannot be used during pregnancy.

Who Might Be a Better Candidate for Each

GLP-1 medications may be particularly suitable if you have type 2 diabetes or prediabetes, as they help with blood sugar control. They're also a good option if you have cardiovascular disease, as some GLP-1s have shown heart health benefits. If you're sensitive to stimulants or have anxiety, GLP-1s won't affect your nervous system the same way.

Qsymia might be considered if you haven't responded to other weight loss medications, prefer an oral medication to injections, or if cost is a primary concern, as it's sometimes less expensive than branded GLP-1 medications.

A Note on Gender Differences

Women of childbearing age should know that Qsymia requires enrollment in a pregnancy prevention program due to the risk of birth defects from topiramate. Reliable contraception is mandatory while taking it. GLP-1 medications don't carry the same pregnancy restrictions, though they're not studied or recommended during pregnancy. Women should also be aware that hormonal changes around menopause can affect how weight loss medications work, something worth discussing with your doctor regardless of which option you choose.

Cost and Accessibility

Cost can be a significant factor. Brand-name GLP-1 medications can be expensive without insurance, often over $1,000 per month. However, compounded versions of semaglutide and tirzepatide have become more accessible and affordable options.

Qsymia's cost varies but is generally in the range of $150-200 per month without insurance, though prices fluctuate.

Insurance coverage varies widely for both medication types, and prior authorization is often required.

The Bottom Line

Both GLP-1 medications and Qsymia can be effective tools for weight management when combined with lifestyle changes. GLP-1s represent newer technology that works with your body's hormonal systems and generally shows higher average weight loss in clinical trials. Qsymia is an established option that combines appetite suppression with stimulant effects.

The right choice depends on your individual health profile, other medical conditions, medication preferences, and how your body responds. This is a decision best made with a healthcare provider who knows your complete medical history.

From the Ozari Care Team

One of the most important factors in success with any weight loss medication is consistency and proper dosing adjustments. We find that patients who start low, increase slowly, and maintain open communication about side effects have the best outcomes. Remember that these medications work best as part of a comprehensive approach that includes nutrition and movement that feels sustainable for your life.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026